quinazolines has been researched along with 2019 Novel Coronavirus Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthanari, H; Barriot, S; Dionellis, VS; Gamboni, R; Gorgulla, C; Halazonetis, TD; Kratzel, A; Mohr, P; Ossorio, MA; Rempel, S; Rossetti, GG; Thiel, V; Tropia, L | 1 |
| Bansode, D; Goel, T; Jadhav, M; Jain, N; Thakar, S | 1 |
| Krysantieva, AI; Safin, DA; Voronina, JK | 1 |
| Cho, JE; Jang, MS; Jeon, S; Kim, HR; Kim, S; Ko, M; Lee, JY; Myung, S; Park, CM; Park, HG; Shin, YS; Song, JH | 1 |
| Djulbegovic, B; Hozo, I; Weiss, DJ | 1 |
| Biswal, HS; Rajan, N; Rana, A; Samal, A; Vivek-Ananth, RP | 1 |
| Abdool Karim, SS; Baden, LR; Morrissey, S; Rubin, EJ | 1 |
| Choudhir, G; Kumar, A; Mishra, A; Pathak, Y; Tripathi, V | 1 |
1 review(s) available for quinazolines and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
An Explicative Review on the Progress of Quinazoline Scaffold as Bioactive Agents in the Past Decade.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antimalarials; Antineoplastic Agents; COVID-19; Humans; Quinazolines | 2023 |
7 other study(ies) available for quinazolines and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Non-covalent SARS-CoV-2 M
Topics: Binding Sites; Coronavirus 3C Proteases; COVID-19; Crystallography, X-Ray; Humans; Molecular Conformation; Molecular Docking Simulation; Nitriles; Protease Inhibitors; Quinazolines; Recombinant Proteins; SARS-CoV-2; Virus Replication | 2022 |
A Novel Ambroxol-Derived Tetrahydroquinazoline with a Potency against SARS-CoV-2 Proteins.
Topics: Ambroxol; Coronavirus Papain-Like Proteases; COVID-19; Humans; Molecular Docking Simulation; Quinazolines; SARS-CoV-2 | 2023 |
Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model.
Topics: Acetamides; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; COVID-19; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Quinazolines; Rats; SARS-CoV-2 | 2023 |
Evaluation of the U.S. governors' decision when to issue stay-at-home orders.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Decision Making; Humans; Models, Statistical; Pandemics; Pneumonia, Viral; Quinazolines; SARS-CoV-2; State Government; United States | 2020 |
In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Topics: Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Binding Sites; Cathepsin L; Coronavirus Infections; Coumarins; COVID-19; Gene Expression; High-Throughput Screening Assays; Host-Pathogen Interactions; Humans; India; Molecular Docking Simulation; Molecular Dynamics Simulation; Monosaccharides; Pandemics; Phytochemicals; Plants, Medicinal; Pneumonia, Viral; Protease Inhibitors; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Quinazolines; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Thermodynamics; Virus Internalization | 2020 |
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
Topics: Adenosine Monophosphate; Africa; Age Factors; Alanine; Antibodies, Neutralizing; Azabicyclo Compounds; Communicable Disease Control; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Humans; Immunization Programs; Mutation; Patient Acuity; Quinazolines; Risk Factors; SARS-CoV-2; Sequence Analysis, RNA; South Africa; Virulence | 2021 |
Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.
Topics: Acetates; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Drug Repositioning; Humans; Molecular Docking Simulation; Quinazolines; Rifampin; SARS-CoV-2; Viral Proteases | 2021 |